Table:
begin	end	state
1	19	cytoplasmic
20	37	transmembrane
38	47	non-cytoplasmic
48	70	transmembrane
71	92	cytoplasmic
93	115	transmembrane
116	126	non-cytoplasmic
127	148	transmembrane
149	156	cytoplasmic
157	181	transmembrane
182	201	non-cytoplasmic
202	224	transmembrane
225	243	cytoplasmic
244	263	transmembrane
264	276	non-cytoplasmic
277	300	transmembrane
301	337	cytoplasmic
338	357	transmembrane
358	362	non-cytoplasmic
363	389	transmembrane
390	403	cytoplasmic
404	427	transmembrane
428	432	non-cytoplasmic
433	452	transmembrane
453	468	cytoplasmic

Input:
>WP_082353324.1 NCBI__GCF_001277995.1:WP_082353324.1
MSDNAAPDTHLHRGLSNRHLQLIAIGGAIGTGLFMGSGKTISVAGPSVILVYAIIGFMLF
FVMRAMGELLLANLNYKSLRDAVSDILGPGAGFVTGWTYWFCWIATGMADIVAITGYTQY
WWPEIPLWLPGVLTIIVLFALNLAAVRLFGEMEFWFAIIKIVAIVALIAVGFFMVITAFG
APNGTTASFNNLIEHGGFFPNGITGFLAGFQIAIFAFVGIELAGTAAAETKDPETTLPRA
INSIPIRIVVFYVLALAVIMMVTPWNEVSPDNSPFVQMFALAGIPAAAGIINFVVITSAA
SSANSGIFSTSRMLYGLSLEGAAPKRWGVLSKRQVPARGLTFSVLCLIPAVGLLYAGGTV
IEAFTLITTVSSVLFMVVWSYILVAYIVYRRRNPELHEKSVFKMPGGVVMAVVVLVFFVA
MLGVLSLETDTRTALLATPVWFIILGVGWFATGGAKGAQRRIQIHERV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server